N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?

Research output: Contribution to journalLetterOtherpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)2362 - 2363
Number of pages2
JournalTransfusion
Volume54
Issue number9
DOIs
Publication statusPublished - 2014

Cite this